Cargando…
Response to letter entitled: Tixagevimab/cilgavimab pre-exposure prophylaxis and breakthrough infection risk in vaccinated solid organ transplant recipients: Concern for immortal time bias effect
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907783/ https://www.ncbi.nlm.nih.gov/pubmed/36758748 http://dx.doi.org/10.1016/j.ajt.2023.01.009 |
| _version_ | 1784884241875599360 |
|---|---|
| author | Al Jurdi, Ayman Morena, Leela Riella, Leonardo V. |
| author_facet | Al Jurdi, Ayman Morena, Leela Riella, Leonardo V. |
| author_sort | Al Jurdi, Ayman |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9907783 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99077832023-02-09 Response to letter entitled: Tixagevimab/cilgavimab pre-exposure prophylaxis and breakthrough infection risk in vaccinated solid organ transplant recipients: Concern for immortal time bias effect Al Jurdi, Ayman Morena, Leela Riella, Leonardo V. Am J Transplant Letter to the Editor American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. 2023-03 2023-02-08 /pmc/articles/PMC9907783/ /pubmed/36758748 http://dx.doi.org/10.1016/j.ajt.2023.01.009 Text en © 2023 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Al Jurdi, Ayman Morena, Leela Riella, Leonardo V. Response to letter entitled: Tixagevimab/cilgavimab pre-exposure prophylaxis and breakthrough infection risk in vaccinated solid organ transplant recipients: Concern for immortal time bias effect |
| title | Response to letter entitled: Tixagevimab/cilgavimab pre-exposure prophylaxis and breakthrough infection risk in vaccinated solid organ transplant recipients: Concern for immortal time bias effect |
| title_full | Response to letter entitled: Tixagevimab/cilgavimab pre-exposure prophylaxis and breakthrough infection risk in vaccinated solid organ transplant recipients: Concern for immortal time bias effect |
| title_fullStr | Response to letter entitled: Tixagevimab/cilgavimab pre-exposure prophylaxis and breakthrough infection risk in vaccinated solid organ transplant recipients: Concern for immortal time bias effect |
| title_full_unstemmed | Response to letter entitled: Tixagevimab/cilgavimab pre-exposure prophylaxis and breakthrough infection risk in vaccinated solid organ transplant recipients: Concern for immortal time bias effect |
| title_short | Response to letter entitled: Tixagevimab/cilgavimab pre-exposure prophylaxis and breakthrough infection risk in vaccinated solid organ transplant recipients: Concern for immortal time bias effect |
| title_sort | response to letter entitled: tixagevimab/cilgavimab pre-exposure prophylaxis and breakthrough infection risk in vaccinated solid organ transplant recipients: concern for immortal time bias effect |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907783/ https://www.ncbi.nlm.nih.gov/pubmed/36758748 http://dx.doi.org/10.1016/j.ajt.2023.01.009 |
| work_keys_str_mv | AT aljurdiayman responsetoletterentitledtixagevimabcilgavimabpreexposureprophylaxisandbreakthroughinfectionriskinvaccinatedsolidorgantransplantrecipientsconcernforimmortaltimebiaseffect AT morenaleela responsetoletterentitledtixagevimabcilgavimabpreexposureprophylaxisandbreakthroughinfectionriskinvaccinatedsolidorgantransplantrecipientsconcernforimmortaltimebiaseffect AT riellaleonardov responsetoletterentitledtixagevimabcilgavimabpreexposureprophylaxisandbreakthroughinfectionriskinvaccinatedsolidorgantransplantrecipientsconcernforimmortaltimebiaseffect |